PMID- 9361945 OWN - NLM STAT- MEDLINE DCOM- 19971212 LR - 20221207 IS - 0902-0063 (Print) IS - 0902-0063 (Linking) VI - 11 IP - 5 Pt 2 DP - 1997 Oct TI - HLA-DQ matching in cadaveric renal transplantation. PG - 480-4 AB - The impact of matching for the human leukocyte antigen (HLA)-DQ phenotype in cadaveric renal transplantation is unclear. We analyzed the effect of matching serologically defined HLA-DQ phenotypes on renal allograft survival in 12,050 first cadaveric renal transplants (recipients were 63.5% white and 36.5% African-American). Recipients were entered into the South-Eastern Organ Procurement Foundation (SEOPF) database between 1 October 1987 and 6 June 1995. A series of life table analyses were done to test the equality of survival curves for HLA-DQ match, both alone and accommodating for differences in recipient race and HLA-DR match. Cox regression models were then performed to detect differences in allograft survival based upon HLA-DQ match. Initial adjustments were done by recipient race. Subsequent adjustments were done by recipient and donor race, age and sex, cold ischemia time (CIT), body mass index (BMI), cyclosporine A (CyA) use, peak panel reactive antibody (PRA) titer, year of transplant, presence of diabetes mellitus (DM), and degree of HLA-A,B and HLA-DR match as covariates. The effect of varying degrees of HLA-DQ match on graft survival were similar between the two races (p = 0.87). In all recipients, an 8.3% reduction in graft failure was observed for each increase in HLA-DQ match using the Cox regression model adjusted only for recipient race (p = 0.004). A non-significant 3.0% reduction in graft failure (p = 0.38) was observed for each level of increasing HLA-DQ match when using the Cox regression model adjusted for recipient and donor race, age and sex, CIT, BMI, CyA use, year of transplant, DM, HLA-A,B and -DR match. In this model, superior HLA-A,B match and HLA-DR match, recipient and donor age, male donor sex, shorter CIT, white race of recipient, lower peak PRA, CyA use, and absence of DM significantly improved graft survival (all < or = 0.004). We conclude that HLA-DQ matching does not significantly affect cadaveric renal allograft survival once adjusted for other known predictors of graft outcome. FAU - Freedman, B I AU - Freedman BI AD - Department of Medicine, Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, North Carolina 27157-1053, USA. FAU - Thacker, L R AU - Thacker LR FAU - Heise, E R AU - Heise ER FAU - Adams, P L AU - Adams PL LA - eng PT - Journal Article PL - Denmark TA - Clin Transplant JT - Clinical transplantation JID - 8710240 RN - 0 (Antibodies) RN - 0 (HLA-A Antigens) RN - 0 (HLA-B Antigens) RN - 0 (HLA-DQ Antigens) RN - 0 (Immunosuppressive Agents) RN - 83HN0GTJ6D (Cyclosporine) SB - IM MH - Age Factors MH - Antibodies/analysis MH - Black People/genetics MH - Body Mass Index MH - Cadaver MH - Cold Temperature MH - Cyclosporine/therapeutic use MH - Databases as Topic MH - Diabetes Mellitus/surgery MH - Female MH - Forecasting MH - Graft Survival MH - HLA-A Antigens/analysis MH - HLA-B Antigens/analysis MH - HLA-DQ Antigens/*analysis/genetics MH - *Histocompatibility MH - Humans MH - Immunosuppressive Agents/therapeutic use MH - Kidney Transplantation/*immunology MH - Life Tables MH - Male MH - Organ Preservation MH - Phenotype MH - Proportional Hazards Models MH - Sex Factors MH - Transplantation, Homologous MH - Treatment Outcome MH - White People/genetics EDAT- 1997/11/15 00:00 MHDA- 1997/11/15 00:01 CRDT- 1997/11/15 00:00 PHST- 1997/11/15 00:00 [pubmed] PHST- 1997/11/15 00:01 [medline] PHST- 1997/11/15 00:00 [entrez] PST - ppublish SO - Clin Transplant. 1997 Oct;11(5 Pt 2):480-4.